MedTrace Logo

Acid Tranexamic Effectiveness in Reducing the Intraoperative Bleeding in Palatoplasty

NCT02422056 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2015-04-21

No results posted yet for this study

Summary

Randomized study evaluating the role of tranexamic acid in reducing intraoperative bleeding in palatoplasty.

Conditions

Interventions

DRUG

Tranexamic Acid

Tranexamic acid bolus of 10 mg / kg at the beginning of palatoplasty, followed by infusion of 1 mg / kg / h until the end of the procedure

DRUG

Saline

Infusion of saline in the same rate used for the intervention group

Sponsors & Collaborators

  • Professor Fernando Figueira Integral Medicine Institute

    lead OTHER

Principal Investigators

  • Guilherme C Arantes · Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2015-02-28
Completion
2015-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02422056 on ClinicalTrials.gov